Baofeng Liu

Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.

Ziyan Wang, Chao Zhang, Xinxing Ma, 2021, Vaccine.

Safety evaluation of revefenacin at the approved dose in patients with chronic obstructive pulmonary disease: A meta-analysis

Baofeng Liu, Shuangjiang Zan, W. Luo, 2022, Heart & Lung.

Acute toxicity, 28-day repeated-dose toxicity and toxicokinetic study of timosaponin BII in beagle dogs

Jie Zhang, Xiao-ming Zhong, Hongtao Jin, 2021, Journal of Asian natural products research.

Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.

F. Luo, Rong Yang, Baofeng Liu, 2021, Vaccine.

Acute toxicity, 28‐day repeated‐dose toxicity and toxicokinetic study of timosaponin BII in rats

Jie Zhang, B. Ma, N. Lin, 2017, Regulatory toxicology and pharmacology : RTP.

Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally

Xingli Xu, Ying Zhang, Qihan Li, 2023, Human vaccines & immunotherapeutics.